JT
EWTX icon

Jupiter Topco’s Edgewise Therapeutics EWTX Stock Holding History

Jupiter Topco’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$247M Buy
+6,075,331
New +$209M 0.1% 190

Other funds holding EWTX

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco's EWTX Position: Q2 2026 in Review

Jupiter Topco opened a new position in Edgewise Therapeutics (EWTX) in Q2 2026: 6,075,331 shares worth $247M. The stake represents 0.1% of the portfolio and ranks #190 among its holdings.

205 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Jupiter Topco held 6,075,331 shares of Edgewise Therapeutics worth $247M as of Q2 2026.
  • Edgewise Therapeutics was a new Jupiter Topco position in Q2 2026.
  • Edgewise Therapeutics made up 0.1% of Jupiter Topco's portfolio in Q2 2026, its #190 holding.
  • 205 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.